Choosing the right IOL when considering cataract surgery
April 6, 2023
What’s the difference between Diffractive and non-diffractive EDOF IOLs?
Despite the fact that Macular Degeneration considered as a disease of kings, now it affects and leads to blindness not only to a privileged society. The light of hope was received from a group of American ophthalmologists who saved four patients from blindness with a new method that’s described in the Journal of Translational
Medicine.
Because life – if it really is life and not a Hollywood scheme – is full of surprises, you never know what you’ll get with your health. As one friend of mine says, “I never thought that I’d have that «literary disease» with the funny name!” I’m not going to tell you what he has, but the word has four letters, ends with a T, and used to be considered the disease of kings, although now it plagues those not-so-prosperous. Either way, it can call for a really monotonous diet.
Macular degeneration has to do with the loss of central vision, and is in the top four causes of blindness. It’s usually seen among the elderly. I hope that you never experience it, but if you reach a ripe old age you’ll have to think about it – there’s a light at the end of the tunnel, though!
Recently, a group of American ophthalmologists saved four patients from blindness with a new method that’s described in the Journal of Translational Medicine. In preliminary studies with animals, it was discovered that it’s possible to stop the process, and even restore vision, by transplanting the pigment layer of the epithelium. Problems with this layer cause blindness – photoreceptors die and vision is blurry, kind of like Monet’s paintings but not as beautiful. It’s hard to recognize faces or read, and it ends with no vision left at all.
The implant, as already stated, was in the cellular layer of the pigment epithelium. And where do they get it? From embryonic stem cells. Five people participated in the experiment, and four of them received the implant, which they observed throughout a year. In all four, the implant took hold and the epithelium was restored – new photoreceptors even began to grow!
S.V.
What’s the difference between Diffractive and non-diffractive EDOF IOLs?
We will open up about whether there is at least something beautiful behind these magic words – macular degeneration and diabetic retinopathy. What kind of unpleasant disease lies under such an interesting "keratoconus" and what is the connection with the cone?
For the first time in history, a robot called PRECEYES participated in an operation. The task was to dissect a specific membrane in the macula, a yellow spot of patients with macular degeneration. Results from six patients, operated on by robots, were compared with six others operated on by humans, but in terms of speed, you might be surprised that man won. Humans 1.5 minutes against robots 5.
The retina is a portal to your brain. According to new data, Alzheimer’s can show itself through some eye diseases that affect the retina. If problems begin in retina, it could be a symptom of physiological abnormalities in the brain. Also, retinal problems can indicate such diseases as diabetes, atherosclerosis. etc.
Researchers observed a sizable population for 15 years, which demonstrated that the probability of developing macular degeneration was 60% lower in orange lovers than in orange haters. Flavonoids, according to the study's author, are most likely what cause this impact. Numerous authors adore the word "flavonoids" because it is so lovely. However, what are they?
Future is officially here! Optos is the modern diagnostic equipment for systemic and ocular retinal diseases. With the assistance of Optos, ophthalmologist can take a fundus photo and see the rear of the eye for potential retinal tears.
Genentech has created a new delivery method for medications needed to prevent age related macular degeneration (AMD) called Port Delivery System. It resembles a small grain of rice that goes directly into your eye and time-releases medication. Genius!
Finally, there’s a light at the end of the tunnel in the treatment of macular degeneration (MD). Scientists have discovered that the main culprit is an enzyme and trying to determine the level of them in the patient's eyes. This enzyme plays an important role in the destruction of retinal cells and ultimately blindness. But does it mean it's time to throw our hats in the air?
